GlassScriptPhysician profile
Grazia Ferroni
NPI 1891099628
$2,945.16
in general payments reported to CMS, 2019-2025
19 companies · $1,438 in 2025
The $1,438 reported for 2025 was more than what 90% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.70 · 2022: $197 · 2023: $629 · 2024: $666 · 2025: $1,438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,488 · Travel and Lodging: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,487.62 |
| Travel and Lodging | $245.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $818.73 | 2023-2025 | Watchman Flx, S-Icd System Magnet, Watchman Access System |
| Biosense Webster, INC. | $573.83 | 2023-2025 | Carto 3, Soundstar |
| Medtronic, INC. | $316.09 | 2023-2025 | Cobalt Dr Mri Surescan, Micra, Linq II |
| Abbott Laboratories | $199.83 | 2023-2025 | Ensite Precision, Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $172.84 | 2022-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $167.33 | 2022-2025 | Camzyos |
| Abiomed | $158.00 | 2024-2025 | Impella |
| Sanofi-Aventis U.S. LLC | $141.71 | 2024 | |
| Atricure, INC. | $93.13 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Astrazeneca Pharmaceuticals LP | $64.22 | 2024-2025 | Wainua |
| Bayer Healthcare Pharmaceuticals INC. | $59.75 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $44.70 | 2022-2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $34.50 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $24.70 | 2022 | |
| Vital Connect, INC | $20.56 | 2025 | Vitalpatch Rtm |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.95 | 2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $14.70 | 2021 | |
| Irhythm Technologies, INC. | $13.91 | 2023 | Zio Xt Patch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.68 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grazia Ferroni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.